# Determining Lipid Content in Stool After Alpha-cyclodextrin

> **NCT03002168** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 8 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha-cyclodextrin
- **DIETARY_SUPPLEMENT:** Placebo
- **RADIATION:** Triolein radiolabeled with 100 microcuries of 3^Hydrogen
- **RADIATION:** Tripalmitin radiolabeled with 20 microcuries of 14^Carbon

## Key facts

- **NCT ID:** NCT03002168
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-20
- **Primary completion:** 2017-06-05
- **Final completion:** 2017-06-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03002168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03002168, "Determining Lipid Content in Stool After Alpha-cyclodextrin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03002168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*